Adverse event | Trainer 2000[7] Placebo n = 32 | Trainer 2000[7] PEG 10mg/d n = 26 | Trainer 2000[7] PEG 15mg/d n = 26 | Trainer 2000[7] PEG 20mg/d n = 28 | ¶ †Open label van der Lely (2001)[8] PEG n = 160 | ¶¶ ††Open label Scheiber (2007)[21] PEG n = 229 | †††Open label Jehle (2005)[17] PEG n = 10 |
---|---|---|---|---|---|---|---|
Infections | 5* (16%) | 5* (19%) | 4* (15%) | 5* (18%) | 52 (33%) | Â | 1 (10%) |
Headache | 4 (12%) | 3 (12%) | 2 (8%) | 3 (11%) | 41 (26%) | 4 (1.7%) | 3 (30%) |
Injection-site reaction | 0 (0%) | 2 (8%) | 1 (4%) | 3 (11%) | 18 (11%) | 17 (7.4%) | -- |
Pain | 2 (6%) | 2 (8%) | 1 (4%) | 4 (14%) | 36 (23%) | -- | -- |
Diarrhoea | 1 (3%) | 1 (4%) | 0 (0%) | 4 (14%) | 23 (14%) | -- | -- |
Nausea | 1 (3%) | 0 (0%) | 2 (8%) | 4 (14%) | -- | -- | -- |
Flatulence | 0 (0%) | 0 (0%) | 1 (4%) | 3 (11%) | -- | -- | -v |
Influenza-like syndrome | -- | -- | -- | -- | 33 (21%) | -- | -- |
Accidental injury | -- | -- | -- | -- | 28 (18%) | -- | -- |
Hypercholesterolemia | -- | -- | -- | -- | 23 (14%) | -- | -- |
Back pain | -- | -- | -- | -- | 21 (13%) | -- | -- |
Asthenia | -- | -- | -- | -- | 21 (13%) | -- | -- |
Arthralgia | -- | -- | -- | -- | 19 (12%) | -- | -- |
Sinusitis | -- | -- | -- | -- | 16 (10%) | -- | -- |
Insomnia (transient) | -- | -- | -- | -- | -- | -- | 2 (20%) |
Fatigue | -- | -- | -- | -- | -- | -- | 3 (30%) |